T1	Participants 54 74	elective hip surgery
T3	Participants 268 376	Of the 120 patients enrolled, 112 completed the trial; 58 in the treatment group and 54 in the placebo group
T2	Participants 144 207	thromboprophylaxis in patients undergoing total hip replacement
